Published in J Natl Cancer Inst on January 01, 1976
Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev (1998) 1.88
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45
Localization of a gene for expression of mouse mammary tumor virus antigens in the GR/Mtv-2- mouse strain. J Exp Med (1980) 1.17
Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes. BMC Genomics (2009) 0.82
Pale cell carcinoma: ultrastructure of a hormone-dependent mammary tumor in GR mice. Am J Pathol (1981) 0.75
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem (1987) 2.94
Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40
Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (1984) 2.12
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Studies of genetic transmission of mammary tumour virus by C3Hf mice. Int J Cancer (1975) 1.92
Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus. Cell (1981) 1.89
Variations among sublines of inbred AKR mice. Nat New Biol (1973) 1.78
H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun (1988) 1.73
Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J Histochem Cytochem (1986) 1.61
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol (2000) 1.60
A new H-2-linked mutation, rds, causing retinal degeneration in the mouse. Tissue Antigens (1978) 1.54
Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun (1978) 1.53
Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice. J Virol (1982) 1.53
In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro. Proc Natl Acad Sci U S A (1975) 1.52
Interaction between viral and genetic factors in murine mammary cancer. Adv Cancer Res (1978) 1.51
A new hereditary cataract mouse with lens rupture. Lab Anim (1997) 1.44
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
An improved murine leukemia virus immunofluorescence assay. Virology (1974) 1.39
Localization of a gene controlling the expression of the human transferrin receptor to the region q12 leads to qter of chromosome 3. Cytogenet Cell Genet (1983) 1.34
Identification of the Mtv-2 gene responsible for the early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc Natl Acad Sci U S A (1978) 1.27
Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position. J Immunol (1987) 1.21
Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma (1983) 1.18
Biological and morphological characteristics of mammary tumors in GR mice. J Natl Cancer Inst (1971) 1.17
Impaired maturation of mouse mammary tumor virus precursor polypeptides in lymphoid leukemia cells, producing intracytoplasmic A particles and no extracellular B-type virions. J Virol (1979) 1.17
Localization of a gene for expression of mouse mammary tumor virus antigens in the GR/Mtv-2- mouse strain. J Exp Med (1980) 1.17
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumour Biol (1996) 1.16
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer (2000) 1.15
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11
Detection of antigens of the mouse mammary tumor (MTV) and murine leukemia virus (MuLV) in cells of cultures derived from mammary tumors of mice of several strains. Virology (1971) 1.10
Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells. J Natl Cancer Inst (1975) 1.08
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer (1995) 1.07
Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens. Int J Cancer (1975) 1.06
Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. J Virol (1983) 1.05
Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method. J Nucl Med (1986) 1.04
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int J Cancer (2001) 1.04
Mammary tumor virus (MTV) antigens in normal and mammary tumor-bearing mice. Int J Cancer (1973) 1.03
Antibody-induced modulation and shedding of mammary tumor virus antigens on the surfaces of GR ascites leukemia cells as compared with normal antigens. J Natl Cancer Inst (1976) 1.02
Genetic transmission of mammary tumour virus in the DBAf mouse strain. Int J Cancer (1978) 1.01
Development of a congeneic line of the GR mouse strain without early mammary tumours. Int J Cancer (1977) 1.01
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop. Tumour Biol (2000) 1.00
Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values. Am J Obstet Gynecol (1996) 1.00
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Tumour Biol (1998) 0.99
Genetic mapping of Pim-1 putative oncogene to mouse chromosome 17. Somat Cell Mol Genet (1986) 0.99
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res (1988) 0.99
Characterization and chromosomal distribution of endogenous mouse mammary tumor viruses of European mouse strains STS/A and GR/A. Virology (1985) 0.98
Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine. Lab Invest (1987) 0.98
Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Cutan Pathol (1992) 0.97
Murine leukemia virus group-specific antigen expression in AKR mice. Cancer Res (1974) 0.97
Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogenet (1993) 0.97
Distribution of mouse mammary tumor virus in Asian wild mice. J Virol (1994) 0.95
CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery. Eur J Cancer (1993) 0.95
Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int J Cancer Suppl (1988) 0.94
Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast. Int J Cancer (1999) 0.94
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumour Biol (1998) 0.94
H-2-dependent regulation of the high level of expression of ecotropic murine leukemia virus. J Natl Cancer Inst (1979) 0.94
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes. Cancer Lett (1997) 0.94
The map position of the rds gene on the 17th chromosome of the mouse. Tissue Antigens (1979) 0.94
Chromosomal mapping of the mouse IL-4 and human IL-5 genes. Genomics (1989) 0.93
Tissue and organ distribution of mammary tumor virus antigens in low and high mammary cancer strain mice. Eur J Cancer Clin Oncol (1983) 0.93
Rigid plasma-membrane-derived vesicles, enriched in tumour-associated surface antigens (MLr), occurring in the ascites fluid of a murine leukaemia (GRSL). Int J Cancer (1979) 0.92
Quantitation of virus-induced (MLr) and normal (Thy.1.2) cell surface antigens in isolated plasma membranes and the extracellular ascites fluid of mouse leukemia cells. Cancer Res (1975) 0.92
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma. Blood (2000) 0.91
Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen. Eur J Cancer Clin Oncol (1986) 0.91
Receptors for Fc epsilon and Fc gamma are linked on mouse chromosome 1. J Immunol (1988) 0.91
Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells. J Natl Cancer Inst (1974) 0.91
Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains. Int J Cancer (1973) 0.90
CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies. Anticancer Res (1986) 0.89
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol (1996) 0.89
A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains. Curr Top Microbiol Immunol (1985) 0.88
Tenascin expression in basal cell carcinoma. Br J Dermatol (1992) 0.88
Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays. Clin Chem (1997) 0.88
Monoclonal antibodies against human acid alpha-glucosidase. Biochim Biophys Acta (1981) 0.88
The gene controlling the binding sites of Dolichos biflorus agglutinin, Dlb-1, is on chromosome 11 of the mouse. Genet Res (1986) 0.88
A new locus (Mtv-4) for endogenous mammary tumor virus expression and early mammary tumor development in the SHN mouse strain. J Natl Cancer Inst (1983) 0.87
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine (1976) 0.87
Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies. Cancer Res (1985) 0.87
In vitro differentiation and progression of mouse mammary tumor cells. Cancer Res (1986) 0.87
Levels of mammary tumor virus proteins (MTVp27 and MTVgp52) in the milk of low and high mammary cancer mouse strains of Japanese origin compared with European and American strains. Int J Cancer (1979) 0.86
Novel antigenic specificity involving the blood group antigen, Lea, in combination with onco-developmental antigen, SSEA-1, recognized by two monoclonal antibodies to human milk-fat globule membranes. Biochem Biophys Res Commun (1985) 0.86
AtT20 pituitary tumour cells contain mouse mammary tumour virus and intracisternal A-type particles in addition to murine leukemia virus. Eur J Cell Biol (1985) 0.85
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. J Clin Pathol (2001) 0.85
Characterization and mapping of DNA sequence homologous to mouse U1a1 snRNA: localization on chromosome 11 near the Dlb-1 and Re loci. Somat Cell Mol Genet (1986) 0.85
A radioimmunoassay for virus antibody using binding of 125I-labelled protein A. J Gen Virol (1979) 0.85
Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland. Int J Cancer Suppl (1988) 0.85
Epstein-Barr virus: experimental infection of Callithrix jacchus marmosets. Int J Cancer (1976) 0.84
The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol (1992) 0.84
Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays. Int J Cancer Suppl (1988) 0.84
Functional topography of discrete domains of human CD38. Tissue Antigens (2000) 0.84
Levels of mammary tumor virus in hormone-dependent and -independent mouse mammary tumor cells. Cancer Res (1977) 0.84
A polymorphic repetitive-sequence PR1 family. Evidence for meiotic instability. J Mol Biol (1985) 0.84
Overexpression of the p53 gene product in canine mammary tumors. Oncol Rep (2001) 0.83
Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues. Tumour Biol (1998) 0.83
Responsiveness of mouse mammary tumours to pregnancy. Eur J Cancer (1965) 0.83
Sorbitol dehydrogenase genetics in the mouse: a 'null' mutant in a 'European' C57BL strain. Anim Blood Groups Biochem Genet (1982) 0.83
Distribution and antibody-induced redistribution of a mammary tumor virus-induced and a normal antigen on the surface of mouse leukemia cells. J Natl Cancer Inst (1975) 0.83
CA 125 half-life in ovarian cancer: a multivariate survival analysis. Br J Cancer (1993) 0.83
Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. Cancer Res (1990) 0.83